Posts

Posted on

Morgan Stanley Real Estate Investing Announces Acquisition of French Logistics Portfolio of Five Assets

Morgan Stanley Real Estate Investing Announces Acquisition of French Logistics Portfolio of Five Assets

PARIS–(BUSINESS WIRE)–
Morgan Stanley Investment Management, through investment funds managed by Morgan Stanley Real Estate Investing (MSREI), announced today the acquisition of a portfolio of five French logistics assets. The fully leased portfolio totals approximately 160,000 square meters across established French logistics markets in Paris, Lille, Bordeaux, Nîmes and Tours.

MSREI plans to implement an active asset management strategy across the portfolio to enhance long-term value and support tenant operations. FIRE Asset Management (FIRE) will serve as operating partner for the portfolio.

Charles du Breuil, Head of France for Morgan Stanley Real Estate Investing, said: “This acquisition reflects MSREI’s continued focus on investing in high-quality industrial and logistics real estate supported by strong market fundamentals and durable tenant demand. It further confirms our appetite for the logistics asset class in France. We have a successful track record of logistics acquisitions and disposals in the French market, and we believe this portfolio offers an attractive opportunity to create value through active asset management.”

About Morgan Stanley Real Estate Investing

Morgan Stanley Real Estate Investing is the global private real estate investment management business of Morgan Stanley. One of the most active property investors in the world for over three decades, MSREI employs a patient, disciplined approach through global value-add / opportunistic and regional core / core-plus real estate investment strategies. With 17 offices throughout the U.S., Europe and Asia, regional teams of dedicated real estate professionals combine a unique global perspective with local presence and significant transaction execution expertise. MSREI currently manages $58 billion of gross real estate assets worldwide on behalf of its clients.

About Morgan Stanley Investment Management

Morgan Stanley Investment Management, together with its investment advisory affiliates, has more than 1,300 investment professionals around the world and $2 trillion in assets under management or supervision as of June 30, 2026. Morgan Stanley Investment Management strives to provide outstanding long-term investment performance, service, and a comprehensive suite of investment management solutions to a diverse client base, which includes governments, institutions, corporations and individuals worldwide. For further information about Morgan Stanley Investment Management, please visit www.morganstanley.com/im.

About Morgan Stanley

Morgan Stanley (NYSE: MS) is a leading global financial services firm providing a wide range of investment banking, securities, wealth management and investment management services. With offices in 42 countries, the Firm’s employees serve clients worldwide including corporations, governments, institutions and individuals. For further information about Morgan Stanley, please visit www.morganstanley.com.

Media Relations Contact:

Antonia Zuckmayer

[email protected]

KEYWORDS: France Europe

INDUSTRY KEYWORDS: Professional Services Residential Building & Real Estate Commercial Building & Real Estate Finance Construction & Property Asset Management Banking

MEDIA:

Posted on

Swiss Firms Seek Managed Security as AI Risks Rise

Swiss Firms Seek Managed Security as AI Risks Rise

Budget constraints, talent shortages, sovereignty requirements accelerate demand for in-country cybersecurity services, ISG Provider Lens® report says

Report includes evaluation of consulting services focused on looming threat of quantum computing against data encryption

ZÜRICH–(BUSINESS WIRE)–
Swiss enterprises are moving more cybersecurity work to outside specialists as talent shortages and the increasing danger of AI-enabled attacks make continuous protection harder to sustain internally, according to a new research report published today by Information Services Group (ISG) (Nasdaq: III), a global AI-centered technology research and advisory firm.

The 2026 ISG Provider Lens® Cybersecurity — Services and Solutions report for Switzerland finds that companies are managing cybersecurity in a difficult environment marked by cautious investment, growing regulation and increasingly sophisticated cybercrime. The report evaluates security consulting services that help prepare enterprises for future quantum computing attacks that may break even strong existing encryption methods.

“AI is changing the speed and shape of cyberattacks, while quantum computing poses a long-term risk to encryption,” said Uwe Ladwig, director at ISG. “Swiss organizations are looking for partners that can strengthen protection while respecting local expectations for trust and control.”

Demand for cost-optimized, modular cybersecurity services is increasing, especially among midsize companies and local government agencies. These organizations often want straightforward services that allow them to focus on core operations, while larger enterprises also seek adaptable options as budget constraints affect security planning. In managed security services, many Swiss buyers prefer local operations to support digital sovereignty and the market’s emphasis on Swissness.

AI-powered phishing, ransomware and supply chain attacks are becoming more sophisticated, making continuous threat protection a higher priority for enterprises. Nearly half of surveyed Western European decision-makers rank continuous threat protection and response, including through a security operations center, among their top five cybersecurity implementation priorities. Providers of security operations centers and managed detection and response services are combining automation and AI with human expertise to help clients respond more quickly to changing threats.

Swiss enterprises are also beginning to address the long-term risks that quantum computing could pose to encrypted data. Post-quantum encryption consulting is becoming more important, especially for industries with significant digital assets such as banks and insurance companies. Attackers are already using the Harvest Now, Decrypt Later strategy, capturing data in anticipation of stronger decryption capabilities in the future. This makes cryptography inventories and migration planning urgent even before quantum technology becomes commercially viable, ISG says.

“The Swiss market rewards providers that understand security for, with and against AI,” said Frank Heuer, principal analyst and lead author of the report. “Swiss-based operations, regulatory knowledge and post-quantum encryption capabilities are becoming more important as enterprises seek resilience without losing control of sensitive data.”

The report also explores other trends shaping Switzerland’s cybersecurity market, including demand for integrated IT and security services and the growing importance of delivery models that serve both large enterprises and midsize organizations.

For more insights into the cybersecurity-related challenges faced by enterprises in Switzerland, plus ISG’s advice for overcoming them, see the ISG Provider Lens Focal Points briefing here.

The report evaluates the capabilities of 38 providers across five quadrants: Strategic Security Services, Technical Security Services, Next-Gen SOC/MDR Services, Next-Gen SOC/MDR Services — Large Accounts and Next-Gen SOC/MDR Services — Midmarket.

The report names InfoGuard and Swisscom as Leaders in all five quadrants. Accenture, Atos, Deutsche Telekom, HCLTech, IBM and UMB are named as Leaders in four quadrants each. Capgemini and Wipro are named as Leaders in three quadrants each. iSPIN, Orange Cyberdefense, TCS and United Security Providers are named as Leaders in two quadrants each. Aveniq, Axians, Bechtle, Deloitte, DXC Technology, EY, Infosys, KPMG, Kudelski Security and Wavestone are named as Leaders in one quadrant each.

In addition, Kudelski Security is named as a Rising Star — a company with a “promising portfolio” and “high future potential” by ISG’s definition — in two quadrants. NTT DATA and Ontinue are named as Rising Stars in one quadrant each.

In the area of customer experience, EY is named the global ISG CX Star Performer for 2026 among Cybersecurity providers. EY earned the highest customer satisfaction scores in ISG’s Voice of the Customer survey, part of the ISG Star of Excellence™ program, the premier quality recognition for the technology and business services industry.

Customized versions of the report are available from InfoGuard and Swisscom.

The 2026 ISG Provider Lens Cybersecurity — Services and Solutions report for Switzerland is available to subscribers or for one-time purchase on this webpage.

About ISG

ISG (Nasdaq: III) is a global AI-centered technology research and advisory firm. A trusted partner to more than 900 clients, including 75 of the world’s top 100 enterprises, ISG is a long-time leader in technology and business services that is now at the forefront of leveraging AI to help organizations achieve operational excellence and faster growth. The firm, founded in 2006, is known for its proprietary market data and research, in-depth knowledge and governance of provider ecosystems, and the expertise of its 1,500 professionals worldwide working together to help clients maximize the value of their technology investments.

Press Contacts:


Laura Hupprich, ISG

+1 203-517-3132

[email protected]

Philipp Jaensch, ISG

+49 151 730 365 76

[email protected]

KEYWORDS: Europe Switzerland United States North America

INDUSTRY KEYWORDS: Security Data Management Technology Artificial Intelligence Software

MEDIA:

Logo
Logo
Posted on

Codexis Announces Pricing of Public Offering of Common Stock

REDWOOD CITY, Calif., July 23, 2026 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex oligonucleotide therapeutics, today announced the pricing of an underwritten public offering of 16,666,667 shares of its common stock at a public offering price of $1.50 per share. Net proceeds to Codexis from the offering are expected to be approximately $23.1 million after underwriting discounts and commissions and estimated offering expenses. The offering is expected to close on or about July 27, 2026, subject to customary closing conditions. Codexis has granted the underwriters of the offering the right for a period of 30 days to purchase up to an additional 2,500,000 shares of common stock at the public offering price, less underwriting discounts and commissions.

Codexis intends to use the net proceeds from the offering to fund working capital and other general corporate purposes, including research, development and business activities.

Piper Sandler and Cantor are acting as joint bookrunning managers for the offering. Craig-Hallum is acting as co-manager.

A registration statement relating to these securities has been filed with the U.S. Securities and Exchange Commission (SEC) and was declared effective on May 14, 2024. The offering is being made only by means of a written prospectus and prospectus supplement that will form a part of the registration statement. A preliminary prospectus supplement relating to the offering have been filed with the SEC and are available on the SEC’s website at www.sec.gov. A final prospectus supplement and accompanying prospectus will be filed with the SEC. Copies of the final prospectus supplement and the accompanying prospectus relating to the offering may be obtained, when available, by contacting Piper Sandler & Co., Attention: Prospectus Department, 350 North 5th Street, Suite 1000, Minneapolis, MN 55401, by telephone at (800) 747-3924, or via email at [email protected]; or Cantor Fitzgerald & Co., Attention: Capital Markets, 110 East 59th Street, 6th floor, New York, NY 10022 or by email at [email protected].

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful, prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Codexis, Inc.

Codexis® is a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, leveraging its proprietary CodeEvolver® technology to discover, develop and enhance novel, high-performance enzymes. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis’ unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing, and greater sensitivity in genomic and diagnostic applications.

Forward-Looking Statements

To the extent that statements contained in this press release are not descriptions of historical facts regarding Codexis, they are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor of the Private Securities Litigation Reform Act of 1995, including Codexis’ expected use of the proceeds of the public offering. Such forward-looking statements involve substantial risks and uncertainties that could cause Codexis’ future results, performance or achievements to differ significantly from those expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the uncertainties related to market conditions and the completion of the public offering on the anticipated terms or at all. Codexis undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to Codexis’ business in general, please refer to Codexis’ prospectus supplement filed with the SEC on July 23, 2026, including the documents incorporated by reference therein, which include Codexis’ Quarterly Report on Form 10-Q filed with the SEC on May 7, 2026, and Codexis’ other periodic reports filed with the SEC.

Investor Relations Contact:

Georgia Erbez
(650) 421-8100
[email protected]



Posted on

U.S. Government Affirms Manitowoc’s Anti-Dumping Claim

U.S. Government Affirms Manitowoc’s Anti-Dumping Claim

MILWAUKEE–(BUSINESS WIRE)–
The Manitowoc Company, Inc. (NYSE: MTW), (the “Company” or “Manitowoc”) a leading global provider of engineered lifting solutions, today welcomed the unanimous and bipartisan affirmative decision from the U.S. International Trade Commission and U.S. Department of Commerce finding predatory dumping by producers of lattice-boom crawler cranes from Japan.

Aaron H. Ravenscroft, President and Chief Executive Officer of The Manitowoc Company, Inc., stated, “We are pleased by the U.S. Government’s decision. This outcome helps restore fair competition in the marketplace and supports the long-term strength of our U.S. manufacturing operations and workforce.”

The new antidumping duties are set to go into effect this month. Please refer to the Federal Register at the following link here.

About The Manitowoc Company, Inc.

The Manitowoc Company was founded in 1902 and has over a 120-year tradition of providing high-quality, customer-focused products and support services to its markets. Manitowoc is one of the world’s leading providers of engineered lifting solutions. Manitowoc, through its wholly-owned subsidiaries, designs, manufactures, markets, and supports comprehensive product lines of mobile hydraulic cranes, lattice-boom crawler cranes, boom trucks, and tower cranes under the Aspen Equipment, Grove, Manitowoc, MGX Equipment Services, National Crane, Potain, and Shuttlelift brand names.

Ion Warner

SVP, Marketing and Investor Relations

+1 414-760-4805

[email protected]

KEYWORDS: Wisconsin United States North America

INDUSTRY KEYWORDS: Urban Planning REIT Architecture Other Construction & Property Residential Building & Real Estate Other Energy Commercial Building & Real Estate Other Manufacturing Utilities Construction & Property Oil/Gas Coal Alternative Energy Energy Nuclear Manufacturing Building Systems

MEDIA:

Logo
Logo
Posted on

Scribe Therapeutics Announces Pricing of Upsized Initial Public Offering

ALAMEDA, Calif., July 23, 2026 (GLOBE NEWSWIRE) — Scribe Therapeutics Inc. (“Scribe Therapeutics”) (Nasdaq: SCTX), a clinical-stage biotechnology company engineering purpose-built in vivo CRISPR technologies designed to extend healthy lifespan through disease prevention and durable therapeutic intervention, today announced the pricing of its upsized initial public offering of 8,580,000 shares of its common stock at the high end of the range at a public offering price of $15.00 per share. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be $128.7 million. All shares of common stock to be sold in the offering will be sold by Scribe Therapeutics. In addition, Scribe Therapeutics has granted the underwriters a 30-day option to purchase up to an additional 1,287,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The shares are expected to begin trading on the Nasdaq Global Market on July 24, 2026, under the symbol “SCTX.” The offering is expected to close on July 27, 2026, subject to the satisfaction of customary closing conditions.

Leerink Partners, Goldman Sachs & Co. LLC, Guggenheim Securities and Wells Fargo Securities are acting as joint book-running managers for the offering.

Registration statements relating to these securities have been filed with the Securities and Exchange Commission and became effective on July 23, 2026. The offering is being made only by means of a prospectus. A copy of the final prospectus may be obtained, when available, from: Leerink Partners LLC, Attention: Syndicate Department, 53 State Street, 40th Floor, Boston, MA 02109, by telephone at 1-800-808-7525 ext. 6105 or by email at [email protected]; Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, New York 10282, telephone: 1-866-471-2526, facsimile: 212-902-9316 or by emailing [email protected]; Guggenheim Securities, LLC, Attention: Equity Syndicate Department, 330 Madison Avenue, 8th Floor, New York, NY 10017, by telephone at (212) 518-9544, or by email at [email protected]; and Wells Fargo Securities, LLC, 90 South 7th Street, 5th Floor, Minneapolis, Minnesota 55402, by telephone at (800) 645-3751 (option #5) or by email at [email protected].

In addition to the shares being sold in the initial public offering, Scribe Therapeutics has agreed to sell 500,000 shares of its common stock at $15.00 per share in a concurrent private placement to Sanofi. The sale of the shares of common stock in the concurrent private placement will not be registered under the Securities Act of 1933, as amended. The concurrent private placement is also expected to close on July 27, 2026, subject to the satisfaction of customary closing conditions, including consummation of the initial public offering. The initial public offering is not contingent on the consummation of the concurrent private placement.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities of Scribe, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended.

About Scribe Therapeutics Inc.

Scribe Therapeutics is a clinical-stage biotechnology company engineering CRISPR-based technologies into purpose-built in vivo genetic medicines designed to become standard of care treatments for patients suffering from highly prevalent diseases, starting with cardiometabolic disease. Leveraging its CRISPR by Design™ approach and nature’s blueprint for improved cardiovascular health, Scribe’s initial programs focus on addressing the key drivers of ASCVD such as elevated LDL-C, lipoprotein(a), and triglycerides. The company’s lead candidate, STX-1150, is a novel liver-targeted therapy designed to epigenetically silence the PCSK9 gene and reduce LDL-C levels without inducing permanent DNA changes. To broaden and accelerate the impact of its engineered CRISPR technologies for patients, Scribe has formed strategic collaborations with world-leading pharmaceutical companies including Sanofi and Eli Lilly. Co-founded by Nobel Prize winner Jennifer Doudna and backed by leading life sciences investors, Scribe is advancing scalable, transformative, and preventative genetic medicines with the goal of improving outcomes and democratizing access to the protective effects of beneficial human genetics.

Investor Contact:

Investor Relations, Scribe Therapeutics
[email protected]

Media Contact:

Thermal for Scribe Therapeutics
[email protected]



Posted on

Chimera Investment Corporation Announces Second Quarter 2026 Earnings Release and Conference Call Date

Chimera Investment Corporation Announces Second Quarter 2026 Earnings Release and Conference Call Date

NEW YORK–(BUSINESS WIRE)–
Chimera Investment Corporation (NYSE: CIM) announced today that it will release financial results for the second quarter ended June 30, 2026, before the market opens on Wednesday, August 5, 2026.

The company will host a conference call and live webcast to discuss the results at 8:30 A.M. ET the same day.

Conference Call Details

U.S. Toll Free: (866) 604-1613

International: (201) 689-7810

Webcast: https://www.chimerareit.com/news-events/ir-calendar

Replay Information

U.S. Toll Free: (877) 660-6853

International: (201) 612-7415

Conference ID: 13760724

A replay of the call will be available for a limited time and can be accessed via the dial-in numbers above or through the webcast archive on the company’s website.

If you would like to receive future announcements and updates, please visit www.chimerareit.com, select News & Events, and subscribe to email alerts.

About Chimera Investment Corporation

Chimera Investment Corporation (NYSE: CIM) is a diversified, internally managed REIT, that serves the U.S. residential real estate market. Through its Portfolio Management and Residential Origination segments, the company acquires, manages, finances and originates residential mortgage and real estate-related assets, with the objective of delivering attractive risk-adjusted returns to shareholders.

Additional information is available at www.chimerareit.com.

Investor Relations

888-895-6557

[email protected]

www.chimerareit.com

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Professional Services Residential Building & Real Estate Finance Construction & Property Asset Management REIT

MEDIA:

Posted on

Upstart Receives Conditional Approval from the OCC to Establish Upstart Bank

Upstart Receives Conditional Approval from the OCC to Establish Upstart Bank

BURLINGAME, Calif.–(BUSINESS WIRE)–
Upstart Holdings, Inc. (NASDAQ: UPST), the leading artificial intelligence (AI) lending marketplace, today announced that the Office of the Comptroller of the Currency (OCC) has granted conditional approval for the company to establish Upstart Bank, N.A.

The charter would allow Upstart to reduce operational, regulatory, and financial complexity for itself as well as for its third-party capital partners. The conditional approval follows Upstart’s application, submitted in March 2026, and represents a key milestone toward operating the first nationally chartered bank built from the ground up with AI-powered underwriting.

“Conditional approval from the OCC is an important milestone for Upstart Bank and we will continue to work with the OCC, the FDIC, and the Federal Reserve on the remaining steps,” said Paul Gu, Upstart’s Co-Founder and CEO. “Upstart Bank will allow us to lower the cost of lending and bring our full product offering to all 50 states, advancing our mission to radically reduce the cost and complexity of credit for all Americans.”

“It’s important for the public to understand that efficiency doesn’t diminish oversight,” said Annie Delgado, Upstart’s Chief Risk Officer and the proposed Chief Executive Officer of Upstart Bank, N.A. “A well-run charter process can be both timely and rigorous. We’ve been challenged extensively throughout the process, and that’s exactly what should happen when an institution is seeking the privilege of becoming a national bank.”

As previously announced, Upstart Bank, N.A. is expected to be based in Delaware, will not have physical branches, and will be able to originate loans to consumers nationwide and accept Federal Deposit Insurance Corporation (FDIC) insured deposits. Consistent with prior disclosures, banks, credit unions, and institutional credit funds are expected to continue to purchase the vast majority of loans originated on the Upstart platform; Upstart Bank, N.A. is intended to complement, not replace, these funding partnerships.

Upstart’s applications to the FDIC for deposit insurance and to the Federal Reserve to become a bank holding company remain pending. Upstart Bank, N.A. will not commence operations until all required approvals are received and the conditions of the OCC’s approval are satisfied, including capitalization, governance, and operational readiness requirements customary for de novo national bank charters. Upstart has been advised by the Klaros Group on matters related to its de novo charter application to form its bank.

About Upstart

Upstart (NASDAQ: UPST) is the leading AI lending marketplace, connecting millions of consumers to more than 100 banks and credit unions that leverage Upstart’s AI models and cloud applications to deliver superior credit products. With Upstart AI, lenders can approve more borrowers at lower rates while delivering the exceptional digital-first experience customers demand. More than 90% of loans are fully automated, with no human intervention by Upstart. Founded in 2012, Upstart’s platform includes personal loans, automotive loans, home equity lines of credit, and Upstart’s new Cash Line product, a revolving line of credit. Upstart is based in Burlingame, California.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact could be deemed forward-looking, including, but not limited to, statements regarding Upstart Bank N.A.’s regulatory structure and approvals; operational and financial impacts; funding and capital structure; and borrower and partner benefits.

Risks that contribute to the uncertain nature of the forward-looking statements include, among others, the possibility that regulatory approvals are denied, delayed, conditioned, or limit anticipated benefits; changes in applicable laws or supervisory expectations; risks associated with operating a bank; the Company’s ability to realize anticipated efficiencies, cost reductions, or funding benefits; and the continued participation of funding partners on the platform; as well as other risks and uncertainties relating to the Company listed or described from time to time in the Company’s filings with the Securities and Exchange Commission (the “SEC”), copies of which may be obtained by visiting our investor relations website or the SEC’s. All forward-looking statements are based on information and estimates available to the Company at the time of this press release. Except as required by law, the Company assumes no obligation to update any of the statements in this press release.

Investors

Sonya Banerjee

[email protected]

Press

Eric Smith

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Professional Services Technology Software Finance Fintech Artificial Intelligence Banking

MEDIA:

Logo
Logo
Posted on

Provident Financial Holdings Announces Quarterly Cash Dividend

RIVERSIDE, Calif., July 23, 2026 (GLOBE NEWSWIRE) — Provident Financial Holdings, Inc. (“Company”), NASDAQ GS: PROV, the holding company for Provident Savings Bank, F.S.B., today announced that the Company’s Board of Directors declared a quarterly cash dividend of $0.14 per share. Shareholders of the Company’s common stock at the close of business on August 13, 2026 will be entitled to receive the cash dividend. The cash dividend will be payable on September 3, 2026.

Safe-Harbor Statement

Certain matters in this News Release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may relate to, among others, expectations of the business environment in which the Company operates, projections of future performance, perceived opportunities in the market, potential future credit experience, and statements regarding the Company’s mission and vision. These forward-looking statements are based upon current management expectations, and may, therefore, involve risks and uncertainties. The Company’s actual results, performance, or achievements may differ materially from those suggested, expressed, or implied by forward-looking statements as a result of a wide range of factors including, but not limited to, the general business environment, interest rates, the California real estate market, competitive conditions between banks and non-bank financial services providers, regulatory changes, and other risks detailed in the Company’s reports filed with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended June 30, 2025.

     
Contact: Donavon P. Ternes Peter C. Fan
  President and Senior Vice President and
  Chief Executive Officer Chief Financial Officer
  (951) 686-6060  



Posted on

NVIDIA and KAIST Launch Joint AI Research Lab to Accelerate AI Innovation in Korea

Collaboration Will Provide World-Class AI Infrastructure, Research Funding, Internships and Joint Appointments to Advance Agentic AI Model Development for Korea

News Summary:

  • NVIDIA and KAIST are launching a joint AI research lab at the KAIST Kim Jaechul Graduate School of AI in Seoul, dedicated to advancing agentic AI models and agent systems built for South Korea’s industries, language and future.
  • The collaboration includes compute contributions, funding for at least 10 KAIST researchers annually with NVIDIA internships, plus full-time NVIDIA roles for top Korean researchers — creating new pathways for Korea’s AI talent.
  • A core focus is developing models optimized for Korea, using NVIDIA Nemotron open models and local NVIDIA Cloud Partner infrastructure to build a pipeline from academic research to enterprise and national AI deployments.

SANTA CLARA, Calif. and SEOUL, July 23, 2026 (GLOBE NEWSWIRE) — NVIDIA and the Korea Advanced Institute of Science and Technology (KAIST) today announced the launch of a joint AI research laboratory at the KAIST Kim Jaechul Graduate School of AI in Seoul, dedicated to advancing agentic AI for South Korea.

The collaboration will establish a robust academic AI research program, bringing together NVIDIA full-stack AI expertise, NVIDIA Nemotron™ open models and NVIDIA AI Cloud partner computing with the world-class scientific talent at KAIST, one of Asia’s premier research universities.

“Korea is home to leading AI researchers and is one of the world’s most advanced technology ecosystems,” said Bill Dally, chief scientist and senior vice president of research at NVIDIA. “The joint NVIDIA-KAIST research lab will provide a foundation for the next frontier of AI research to accelerate AI models and agent systems built for Korea’s industries, language and future.”

“AI research is entering a new era — one that requires frontier talent, large-scale infrastructure and deep collaboration across academia and industry,” said Hyunwoo Kim, incoming faculty member at the KAIST Kim Jaechul Graduate School of AI, who will serve as head of the joint NVIDIA-KAIST lab upon joining KAIST. “Together, NVIDIA and KAIST Kim Jaechul Graduate School of AI will pursue ambitious work that helps Korea attract and retain top AI scientists while building lasting ties with NVIDIA’s global research organization.”

Full-Stack Infrastructure, Open Models and Collaboration Fuel Korea’s AI Future

The lab will be established at the KAIST Kim Jaechul Graduate School of AI in Seoul. KAIST, headquartered in the tech hub of Daejeon, has a strong focus on public research spanning engineering, AI, semiconductor technology, robotics and digital humanities.

The joint lab plans to fund at least 10 KAIST researchers annually and provide each with internship opportunities at NVIDIA. In addition, NVIDIA plans to hire exceptional Korean researchers for full-time positions. Together, these efforts will create stronger pathways for Korea’s top AI talent to pursue ambitious research, build long-term careers and deepen global collaboration between academia and industry.

The $300 million collaboration is expected to include $50-million-per-year compute contributions across an initial five-year period. Compute infrastructure from local NVIDIA Cloud Partners will provide researchers with direct access to the latest NVIDIA AI infrastructure.

Among the lab’s priorities will be developing models optimized for the Korean language and Korea-specific use cases, with NVIDIA Nemotron open models to advance the country’s AI capabilities, fostering a pipeline from academic discovery to enterprise and national AI deployments.

About KAIST

The Korea Advanced Institute of Science and Technology (KAIST) is a public research university in Daejeon, South Korea. Founded in 1971, KAIST is consistently ranked among Asia’s top universities in science and engineering and has produced many of Korea’s leading scientists, engineers, and entrepreneurs. For more information, visit www.kaist.ac.kr.

About NVIDIA


NVIDIA
 (NASDAQ: NVDA) is the world leader in AI and accelerated computing.

For further information, contact:

Corporate Communications
NVIDIA Corporation
[email protected]  

PR Office
KAIST
[email protected]

Certain statements in this press release including, but not limited to, statements as to: the joint NVIDIA-KAIST research lab providing a foundation for the next frontier of AI research to accelerate AI models and agent systems built for Korea’s industries, language and future; expectations with respect to NVIDIA’s collaboration with KAIST; expectations with respect to growth, performance, availability, and benefits of NVIDIA’s products, services and technologies, and related trends and drivers; expectations with respect to technology developments, and related trends and drivers; projected market growth and trends; expectations with respect to AI and related industries; and other statements that are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the “safe harbor” created by those sections based on management’s beliefs and assumptions and on information currently available to management and are subject to risks and uncertainties that could cause results to be materially different than expectations. Important factors that could cause actual results to differ materially include: global economic and political conditions; NVIDIA’s reliance on third parties to manufacture, assemble, package and test NVIDIA’s products; the impact of technological development and competition; development of new products and technologies or enhancements to NVIDIA’s existing products and technologies; market acceptance of NVIDIA’s products or NVIDIA’s partners’ products; design, manufacturing or software defects; changes in consumer preferences or demands; changes in industry standards and interfaces; unexpected loss of performance of NVIDIA’s products or technologies when integrated into systems; NVIDIA’s ability to realize the potential benefits of business investments or acquisitions; and changes in applicable laws and regulations, as well as other factors detailed from time to time in the most recent reports NVIDIA files with the Securities and Exchange Commission, or SEC, including, but not limited to, its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Copies of reports filed with the SEC are posted on the company’s website and are available from NVIDIA without charge. These forward-looking statements are not guarantees of future performance and speak only as of the date hereof, and, except as required by law, NVIDIA disclaims any obligation to update these forward-looking statements to reflect future events or circumstances.

© 2026 NVIDIA Corporation. All rights reserved. NVIDIA, the NVIDIA logo and Nemotron are trademarks and/or registered trademarks of NVIDIA Corporation in the U.S. and other countries. Other company and product names may be trademarks of the respective companies with which they are associated. Features, pricing, availability and specifications are subject to change without notice.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/a414b7ed-4e56-4b3e-b323-4737d489e2b0



Posted on

Pelican Acquisition II Corporation Announces Pricing of $75,000,000 Initial Public Offering

NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) — Pelican Acquisition II Corporation (NASDAQ: PLCIU) (the “Company”), a Cayman Islands exempted company, announced that it priced its initial public offering of 7,500,000 units at $10.00 per unit on July 23, 2026. The units will be listed on the Nasdaq Capital Market (“NASDAQ”) and are expected to trade under the ticker symbol “PLCIU” beginning on July 24, 2026. Each unit consists of one ordinary share of the Company and one right, with each right entitling the holder thereof to receive one-tenth (1/10) of one ordinary share upon the consummation of an initial business combination.  

Once the securities comprising the units begin separate trading, the ordinary shares and rights are expected to be listed on NASDAQ under the symbols “PLCI” and “PLCIR”, respectively. The offering is expected to close on July 27, 2026, subject to customary closing conditions.

EarlyBirdCapital, Inc. is acting as sole book-running manager in the offering. EarlyBirdCapital has been granted a 45-day option to purchase up to an additional 1,125,000 units offered by the Company at the initial public offering price to cover over-allotments, if any. 

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on July 23, 2026. The offering is being made only by means of a prospectus. Copies of the prospectus may be obtained, when available, by contacting EarlyBirdCapital, Inc., 366 Madison Avenue, 8th floor, New York, NY 10017, Attention: Syndicate Department, or by calling 212-661-0200. Copies of the registration statement can be accessed through the SEC’s website at www.sec.gov.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Pelican Acquisition II Corporation

Pelican Acquisition II Corporation is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company’s efforts to identify a prospective target business will not be limited to a particular industry or geographic region.

Forward-Looking Statements

This press release includes forward-looking statements that involve risks and uncertainties. Forward-looking statements are statements that are not historical facts. Such forward-looking statements, including with respect to the initial public offering, are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. No assurance can be given that the initial public offering will be completed on the terms described, or at all, or that the net proceeds of the offering will be used as described in the offering prospectus. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.

Contact 
Robert Labbe
Chief Executive Officer
Email: [email protected]
Tel: (212) 612-1400